Your browser doesn't support javascript.
loading
Ongoing Analytical Procedure Performance Verification Using a Risk-Based Approach to Determine Performance Monitoring Requirements.
Borman, Phil J; Guiraldelli, Amanda M; Weitzel, Jane; Thompson, Sarah; Ermer, Joachim; Roussel, Jean-Marc; Marach, Jaime; Sproule, Stephanie; Pappa, Horacio N.
Affiliation
  • Borman PJ; US Pharmacopeia 12601 Twinbrook Pkwy, Rockville, Maryland 20851, United States.
  • Guiraldelli AM; US Pharmacopeia 12601 Twinbrook Pkwy, Rockville, Maryland 20851, United States.
  • Weitzel J; US Pharmacopeia 12601 Twinbrook Pkwy, Rockville, Maryland 20851, United States.
  • Thompson S; AstraZeneca, Silk Road Business Park, Macclesfield, Cheshire SK10 2NA, United Kingdom.
  • Ermer J; US Pharmacopeia 12601 Twinbrook Pkwy, Rockville, Maryland 20851, United States.
  • Roussel JM; US Pharmacopeia 12601 Twinbrook Pkwy, Rockville, Maryland 20851, United States.
  • Marach J; US Pharmacopeia 12601 Twinbrook Pkwy, Rockville, Maryland 20851, United States.
  • Sproule S; US Pharmacopeia 12601 Twinbrook Pkwy, Rockville, Maryland 20851, United States.
  • Pappa HN; US Pharmacopeia 12601 Twinbrook Pkwy, Rockville, Maryland 20851, United States.
Anal Chem ; 96(3): 966-979, 2024 Jan 23.
Article de En | MEDLINE | ID: mdl-38191128
ABSTRACT
The analytical procedure life cycle (APLC) provides a holistic framework to ensure analytical procedure fitness for purpose. USP's general chapter <1220> considers the validation activities that take place across the entire analytical procedure lifecycle and provides a three-stage framework for its implementation. Performing ongoing analytical procedure performance verification (OPPV) (stage 3) ensures that the procedure remains in a state of control across its lifecycle of use post validation (qualification) and involves an ongoing program to collect and analyze data that relate to the performance of the procedure. Knowledge generated during stages 1 (procedure design) and 2 (procedure performance qualification) is used as the basis for the design of the routine monitoring plan to support performance verification (stage 3). The extent of the routine monitoring required should be defined based on risk assessment, considering the complexity of the procedure, its intended purpose, and knowledge about process/procedure variability. The analytical target profile (ATP) can be used to provide or guide the establishment of acceptance criteria used to verify the procedure performance during routine use (e.g., through a system/sample suitability test (SST) or verification criteria applicable to procedure changes or transfers). An ATP however is not essentially required to perform OPPV, and a procedure performance monitoring program can be implemented even if the full APLC framework has not been applied. In these situations, verification criteria can be derived from existing validation or system suitability criteria. Elements of the life cycle approach can also be applied retrospectively if deemed useful.

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Etiology_studies / Risk_factors_studies Langue: En Journal: Anal Chem Année: 2024 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Etiology_studies / Risk_factors_studies Langue: En Journal: Anal Chem Année: 2024 Type de document: Article Pays d'affiliation: États-Unis d'Amérique
...